Literature DB >> 3700024

In vitro production of glycosaminoglycans by retinal microvessel cells and lens epithelium.

A Kennedy, R N Frank, M A Mancini.   

Abstract

Analysis of bovine lens capsules and retinal microvessel basement membranes by cellulose acetate electrophoresis, together with treatment by specific enzymes or by nitrous acid, reveals that heparan sulfate is the only demonstrable glycosaminoglycan (GAG), consistent with the observations of most other investigators on basement membrane preparations from several different tissues. When bovine retinal microvessel pericytes or endothelial cells or bovine lens epithelial cells are grown in culture in the presence of [35S]-sulfate or [3H]-glucosamine, however, both cellulose acetate electrophoresis and gel filtration chromatography reveal that the cultured pericytes synthesize primarily chondroitin sulfate, whereas the lens epithelial cells and microvascular endothelial cells produce a mixture of GAGs consisting of approximately 60% heparan sulfate and 40% chondroitin sulfate. The chondroitin sulfate chains have an Mr of 70,000, but the Mr of the heparan sulfate chains is 10,000, based on gel filtration chromatography on Sepharose CL-6B. Hence, cell culture conditions may produce phenotypic modulation of the biosynthetic capacities of these cells for GAGs. However, the difference between the in vitro and in vivo findings may in part be explained if many of the chondroitin sulfate GAGs synthesized in vitro are cell associated and are not incorporated into the basement membrane.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700024

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  2 in total

1.  Adhesion of lens capsule to intraocular lenses of polymethylmethacrylate, silicone, and acrylic foldable materials: an experimental study.

Authors:  T Oshika; T Nagata; Y Ishii
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

2.  Interferon effect on glycosaminoglycans in mouse glioma in vitro.

Authors:  M Wiranowska; A K Naidu
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.